252 related articles for article (PubMed ID: 15920030)
1. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
Reifenberg K; Lehr HA; Baskal D; Wiese E; Schaefer SC; Black S; Samols D; Torzewski M; Lackner KJ; Husmann M; Blettner M; Bhakdi S
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1641-6. PubMed ID: 15920030
[TBL] [Abstract][Full Text] [Related]
2. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
[TBL] [Abstract][Full Text] [Related]
3. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
Norata GD; Marchesi P; Pulakazhi Venu VK; Pasqualini F; Anselmo A; Moalli F; Pizzitola I; Garlanda C; Mantovani A; Catapano AL
Circulation; 2009 Aug; 120(8):699-708. PubMed ID: 19667236
[TBL] [Abstract][Full Text] [Related]
6. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
[TBL] [Abstract][Full Text] [Related]
7. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
8. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.
Kovacs A; Tornvall P; Nilsson R; Tegnér J; Hamsten A; Björkegren J
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13768-73. PubMed ID: 17702862
[TBL] [Abstract][Full Text] [Related]
9. Chronic immune reactivity against persisting microbial antigen in the vasculature exacerbates atherosclerotic lesion formation.
Krebs P; Scandella E; Bolinger B; Engeler D; Miller S; Ludewig B
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2206-13. PubMed ID: 17656668
[TBL] [Abstract][Full Text] [Related]
10. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
[TBL] [Abstract][Full Text] [Related]
11. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
13. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
14. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice.
Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):347-52. PubMed ID: 16293797
[TBL] [Abstract][Full Text] [Related]
15. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
[TBL] [Abstract][Full Text] [Related]
17. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
[TBL] [Abstract][Full Text] [Related]
18. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
19. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
